Pro Chart

Colgate-Palmolive

NYSE: CL · Real-Time Price · USD
92.22
-0.09 (-0.10%)
At close: Aug 12, 2026, 10:15 AM

Colgate-Palmolive (CL) Stock Price, Analysis & Data

-0.10%
Bid92.31
Market Cap73.52B
Revenue (ttm)21.05B
Net Income (ttm)2.04B
Beta0.33
EPS (ttm)2.54
PE Ratio (ttm)36.31
Forward PE22.49
P/B (ttm)311.55
P/S (ttm)3.49
Earnings DateOct 30, 2026
Ask92.4
Volume421,216
Avg. Volume (20D)5,096,482
Open91.32
Previous Close92.31
Day's Range91.30 - 92.60
52-Week Range74.55 - 99.33
AnalystBuy
Price Target100.5 (8.98%)
Dividends$2.12 (2.28%)
Ex-Dividend DateJul 20, 2026

About CL

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents...

IPO Date May 2, 1973
Employees 33,600
Stock Exchange NYSE
Ticker Symbol CL
Full Company Profile

Financial Performance

In 2025, Colgate-Palmolive's revenue was 20.38B, an increase of 1.4% compared to the previous year's 20.1B. Earnings were 2.13B, a decrease of -26.2%.

Financial Statements

Analyst Forecast

According to 20 analyst ratings, the average rating for CL stock is "Buy". The 12-month stock price forecast is 100.5, which is upside of 8.98% from the latest price.

Stock Forecasts

Earnings Surprise

Colgate-Palmolive has released their quarterly earnings on Jul 31, 2026:
  • Revenue of $5.36B misses estimates by $0, with 4.91% YoY growth.
  • EPS of 0.99 exceeds estimates by 0.04, with 7.61% YoY growth.
  • Colgate-Palmolive is scheduled to release its earnings on Oct 30, 2026, before market opens.
    Analysts project revenue of ... Upgrade
    Page 1 of 2